• Bufalin Targets STK33 to Suppress Triple-Negative Breast Can

  2026-04-20

  This study identifies serine/threonine kinase 33 (STK33) as a direct molecular target of Bufalin in triple-negative breast cancer (TNBC). By elucidating Bufalin's mechanism in degrading STK33 and inhibiting TNBC cell proliferation, the research provides a new therapeutic strategy and expands the molecular understanding of Bufalin as an apoptosis inducer in cancer cells.

• IWR-1-endo: Wnt Signaling Inhibitor for Precision Cell Assay

  2026-04-19

  IWR-1-endo enables highly specific and reproducible inhibition of the Wnt/β-catenin pathway, streamlining advanced workflows in colorectal cancer and regenerative biology. This guide details optimal protocols, real-world troubleshooting, and critical insights from recent single-nucleus profiling studies, positioning IWR-1-endo as a benchmark tool for dissecting Wnt-driven mechanisms.

• Pregnenolone Carbonitrile: Precision in CYP3A Induction & Ne

  2026-04-18

  Pregnenolone Carbonitrile (PCN) enables precise cytochrome P450 CYP3A induction for hepatic detoxification studies, while also demonstrating unique, tissue-specific neuroprotective effects. Explore advanced workflows, antifibrotic applications, and troubleshooting strategies that leverage PCN’s dual mechanistic action, as highlighted by innovative recent research.

• Ruxolitinib Phosphate Induces Apoptosis in Anaplastic Thyroi

  2026-04-17

  A recent study demonstrates that Ruxolitinib phosphate (INCB018424) induces apoptosis and pyroptosis in anaplastic thyroid carcinoma (ATC) by inhibiting DRP1-mediated mitochondrial fission through JAK1/2-STAT3 pathway suppression. These findings highlight a novel mechanism of mitochondrial dynamics regulation, underscoring the compound's translational potential for aggressive thyroid cancer models.

• Losmapimod (GW856553X): Optimizing p38 MAPK Assays in Inflam

  2026-04-16

  Leverage Losmapimod (GW856553X) for high-fidelity modulation of inflammation signaling and vascular function in both cellular and animal models. This guide details validated experimental workflows, troubleshooting insights, and key innovations—empowering researchers to achieve reproducible outcomes in hypertension and COPD research.

• Molidustat (BAY85-3934): Applied Workflows for Renal Anemia

  2026-04-15

  Molidustat (BAY85-3934) empowers researchers to model and modulate erythropoietin production with precise control over the HIF pathway, outperforming traditional EPO-based approaches in chronic kidney disease anemia studies. By leveraging robust workflows and troubleshooting insights, scientists can unlock new avenues in oxygen-sensing research and translational therapy development.

• Efficacy of Antiprotozoal Drugs Against Azumiobodo hoyamushi

  2026-04-14

  This study systematically evaluated the in vitro and in vivo efficacy of diverse antiprotozoal agents—including Fumagillin—against Azumiobodo hoyamushi, the causative agent of soft tunic syndrome in Halocynthia roretzi. The findings inform selection of candidate compounds for disease management in aquaculture and highlight the cross-domain relevance of methionine aminopeptidase-2 inhibitors.

• Gefitinib (ZD1839): Advanced Strategies for Tumor-Stroma Mod

  2026-04-13

  Explore how Gefitinib (ZD1839) empowers researchers to dissect EGFR signaling and therapeutic resistance using next-generation tumor-stroma models. This article delivers unique, evidence-driven insights for optimizing cancer research beyond standard protocols.

• Nascent Cone Precursors as the Earliest Origin of Retinoblas

  2026-04-12

  This study leverages longitudinal analysis of RB1-deficient retinal organoids to pinpoint ATOH7+/RXRγ+ nascent cone precursors as the earliest cellular origin of human retinoblastoma. The findings clarify longstanding questions about tumor initiation in pediatric ocular malignancy and provide a robust in vitro model for studying early tumorigenesis and potential targeted therapies.

• Beclin1 Deficiency Mitigates DOX-Induced Liver Injury via Fe

  2026-04-12

  This study demonstrates that Beclin1 deficiency alleviates doxorubicin-induced liver injury by suppressing both ferroptosis and autophagy. The findings highlight Beclin1 and DHODH as regulatory nodes in hepatocellular oxidative stress, supported by rigorous lipid peroxidation and biomarker analyses.

• Bazedoxifene: Selective Estrogen Receptor Modulator Workflow

  2026-04-11

  Bazedoxifene stands out as a third-generation selective estrogen receptor modulator, enabling precise modeling of estrogen receptor signaling and bone mineral density enhancement in postmenopausal osteoporosis research. Recent cross-domain findings reveal its unique potential for antimalarial repurposing, expanding the experimental toolbox for translational scientists.

• Metoprolol Tartrate: Advanced β1-Adrenergic Blocking in Card

  2026-04-11

  Metoprolol Tartrate stands out as a selective β1-adrenergic blocking agent, enabling precise cardiovascular and hematopoietic research without the off-target effects seen in nonselective β-blockers. Leverage robust experimental workflows, evidence-backed protocol parameters, and troubleshooting strategies to maximize reproducibility and translational relevance.

• PPT (Propyl Pyrazole Triol): Advanced Insights Into Selec...

  2026-04-10

  Explore the advanced mechanisms and research applications of PPT, a selective ERα agonist, in estrogen receptor alpha mediated gene expression and nuclear receptor signaling. This in-depth article provides new perspectives on ERα vs ERβ selectivity, ceRNA networks in oncology, and cutting-edge methodologies for hormone receptor research.

• JZL184 (SKU B1958): Scenario-Driven Solutions for Robust ...

  2026-04-09

  This article delivers an evidence-based, scenario-driven guide to deploying JZL184 (SKU B1958) for endocannabinoid signaling and neuropharmacology research. It addresses real-world experimental challenges, interprets recent literature, and benchmarks APExBIO’s JZL184 against alternative vendors for reproducibility and data quality. Designed for scientists seeking validated, high-purity tools for reliable cell viability, proliferation, or cytotoxicity assays.

• HyperScript™ Reverse Transcriptase: High-Fidelity cDNA Sy...

  2026-04-08

  HyperScript™ Reverse Transcriptase is a thermally stable, genetically engineered M-MLV enzyme optimized for cDNA synthesis from complex or low-abundance RNA templates. Its reduced RNase H activity and high affinity for RNA enable robust performance in qPCR and gene expression workflows. This dossier presents key properties, evidence, and practical guidance for molecular biology applications.

451 records 21/31 page Previous Next First page 上5页 2122232425 下5页 Last page